Impact of the MDR-1 C3435T polymorphism on tacrolimus doses and trough concentrations in renal transplant recipients.

被引：0
|
作者：
Anglicheau, D
Verstruyf, C
Schlageter, MH
Thervet, E
Becquemont, L
Beaune, P
Legendre, C
机构：
[1] Univ St Peres, INSERM U490, Paris, France
[2] Hop St Louis, Serv Nephrol, Paris, France
[3] Hop St Antoine, Serv Pharmacol, F-75571 Paris, France
[4] Hop St Louis, Serv Med Nucl, Paris, France
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：360A / 361A
页数：2
相关论文
共 50 条
  • [1] No influence of the MDR-1 C3435T polymorphism on cyclosporine absorption profiles and tacrolimus dosage or renal function in stable renal transplant recipients.
    Einecke, G
    Goldammer, M
    Mai, I
    Glander, P
    Lorkowski, C
    Fritsche, L
    Neumayer, HH
    Budde, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 881A - 881A
  • [2] MDR-1 C3435T polymorphism has no effect on cyclosporine absorption and tacrolimus dosage or clinical outcome in stable renal transplant recipients.
    Einecke, G
    Goldammer, M
    Mai, I
    Glander, P
    Lorkowski, C
    Fritsche, L
    Neumayer, HH
    Budde, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 234 - 234
  • [3] MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients
    Bonhomme-Faivre, L
    Devocelle, A
    Saliba, F
    Chatled, S
    Maccario, J
    Farinotti, R
    Picard, V
    TRANSPLANTATION, 2004, 78 (01) : 21 - 25
  • [4] Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tada, H
    Tsuchiya, N
    Satoh, S
    Kagaya, H
    Li, Z
    Sato, K
    Miura, M
    Suzuki, T
    Kato, T
    Habuchi, T
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1730 - 1732
  • [5] A model for estimating the impact of new pharmacogenetic tests on local populations: MDR-1 C3435T polymorphism
    Abudu, N
    Valdes, R
    Linder, MW
    CLINICAL CHEMISTRY, 2004, 50 (06) : A130 - A130
  • [6] MDR-1 C3435T genetic polymorphism and tobacco-related lung cancer
    Sinués, B
    Fanlo, A
    Bernal, ML
    Mayayo, E
    Bello, S
    Rubio, E
    Isla, D
    ONCOLOGY, 2003, 64 (02) : 183 - 185
  • [7] No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin a trough concentrations or rejection incidence in stable renal transplant recipients
    von Ahsen, N
    Richter, M
    Grupp, C
    Ringe, B
    Oellerich, M
    Armstrong, VW
    CLINICAL CHEMISTRY, 2001, 47 (06) : 1048 - 1052
  • [8] Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms
    Li, D.
    Gui, R.
    Li, Jin
    Huang, Z.
    Nie, Xinmin
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (09) : 2850 - 2852
  • [9] MDR-1 polymorphism (C3435T) as risk factor for HELLP syndrome in women with preeclampsia.
    Coolman, Marianne
    van Schaik, Ron H. N.
    van der Heiden, Ilse. P.
    Steegers, Eric A. P.
    HYPERTENSION IN PREGNANCY, 2006, 25 : 45 - 45
  • [10] MDR-1 polymorphism C3435T and response to primary chemotherapy in patients with locally advanced breast cancer
    Kafka, A
    Kreienberg, R
    Zeillinger, R
    Deissler, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
12345